Han Xu, Zhang Gao Sen, Li Qi Rui, Zhang Zhen
Department of Ultrasound, The First Hospital of China Medical University, Shenyang, China.
Front Nutr. 2024 Nov 15;11:1422663. doi: 10.3389/fnut.2024.1422663. eCollection 2024.
Muscle wasting syndrome, also known as sarcopenia, is an age-related geriatric condition characterized by a gradual loss of muscle mass, strength, and function. Sarcopenia can be classified into primary and secondary types. Primary sarcopenia is primarily associated with aging, while secondary sarcopenia is caused by systemic diseases such as cancer, diabetes, liver cirrhosis, musculoskeletal disorders, and disuse changes. In recent years, increasing evidence suggests that cardiovascular diseases can promote the occurrence of sarcopenia through various pathophysiological mechanisms. Additionally, sarcopenia increases the risk of adverse outcomes in patients with cardiovascular disease such as rehospitalization and mortality. Therefore, screening and diagnosing sarcopenia are particularly important for patients with cardiovascular diseases. This article provides a brief overview of the research progress on diagnostic methods for sarcopenia in patients with cardiovascular diseases.
肌肉减少症,也称为少肌症,是一种与年龄相关的老年病症,其特征是肌肉质量、力量和功能逐渐丧失。少肌症可分为原发性和继发性类型。原发性少肌症主要与衰老有关,而继发性少肌症则由癌症、糖尿病、肝硬化、肌肉骨骼疾病和废用性改变等全身性疾病引起。近年来,越来越多的证据表明,心血管疾病可通过各种病理生理机制促进少肌症的发生。此外,少肌症会增加心血管疾病患者再次住院和死亡等不良结局的风险。因此,对心血管疾病患者进行少肌症的筛查和诊断尤为重要。本文简要概述了心血管疾病患者少肌症诊断方法的研究进展。